Suppr超能文献

镁对实验性糖尿病甲状腺功能障碍的改善作用也可能预防糖尿病引起的肾脏损害。

Amelioration of thyroid dysfunction by magnesium in experimental diabetes may also prevent diabetes-induced renal impairment.

作者信息

Ige A O, Chidi R N, Egbeluya E E, Jubreel R O, Adele B O, Adewoye E O

机构信息

Applied and Environmental Physiology Unit, Department of Physiology, University of Ibadan, Nigeria.

出版信息

Heliyon. 2019 May 8;5(5):e01660. doi: 10.1016/j.heliyon.2019.e01660. eCollection 2019 May.

Abstract

BACKGROUND

Diabetes mellitus has been reported to cause thyroid dysfunction, which may also impair renal function. Magnesium has been reported to exert ameliorative effects in diabetes mellitus. This study investigated thyroid and renal functions in experimental type-2-diabetic Wistar rats.

METHODS

Experimental type-2-diabetes was induced using short duration high-fat (30%) diet feeding followed by single-dose streptozotocin (35 mg/kg i.p.). Fifty rats were randomly divided into five equal groups consisting of control, diabetes untreated, diabetes treated with either magnesium (250 mg/kg) or metformin (250 mg/kg) and diabetes treated with both metformin and magnesium simultaneously.All treatments were carried out orally for 14days post-diabetes induction. Body weight and blood glucose was monitored using the tail tipping method before diabetes induction and thereafter on days 1,7,14 post-treatment respectively. Thereafter, blood samples were collected by cardiac puncture after light anesthesia into plain and EDTA sample bottles. Total protein, albumin, globulin (plasma) and insulin (serum) were assayed in all samples obtained. Thyroid stimulating hormone (TSH), triiodothyronine, thyroxine was also evaluated (n = 5/group) in serum while blood urea nitrogen (BUN), creatinine was assessed (n = 5/group) in plasma. Kidney homogenates were obtained per group and analyzed for renal superoxide dismutase (SOD), reduced glutathione (GSH) and lipid peroxidation (MDA). Kidney histology was also evaluated per group using both Haematoxylin and Eosin and periodic acid Schiff stains.

RESULTS

Body weight, blood glucose, insulin, renal MDA was increased in diabetic untreated compared to other groups. Reductions (P < 0.05) in TSH, triiodothynine, Renal SOD and GSH levels where observed in diabetic untreated compared to other groups. Renal histology in diabetic untreated showed glomerula sclerosis, fused messengial cells and either collapsed tubular lumen or lumen with eosinophilic renal cast. These pathologies where partially reversed in the other experimental groups.

CONCLUSION

This study suggests that thyroid and renal impairment may be present in experimental type-2-diabetes. Treatment with oral magnesium may cause a partial restoration of thyroid function that may impede the development of renal dysfunction.

摘要

背景

据报道,糖尿病会导致甲状腺功能障碍,这也可能损害肾功能。据报道,镁对糖尿病有改善作用。本研究调查了实验性2型糖尿病Wistar大鼠的甲状腺和肾功能。

方法

采用短期高脂(30%)饮食喂养,随后腹腔注射单剂量链脲佐菌素(35mg/kg)诱导实验性2型糖尿病。50只大鼠随机分为五组,每组数量相等,分别为对照组、未治疗的糖尿病组、用镁(250mg/kg)或二甲双胍(250mg/kg)治疗的糖尿病组以及同时用二甲双胍和镁治疗的糖尿病组。在糖尿病诱导后,所有治疗均口服14天。在糖尿病诱导前以及治疗后第1、7、14天分别使用尾尖采血法监测体重和血糖。此后,在轻度麻醉后通过心脏穿刺采集血样,分别放入普通和EDTA样本瓶中。对所有采集的样本检测总蛋白、白蛋白、球蛋白(血浆)和胰岛素(血清)。同时对血清中的促甲状腺激素(TSH)、三碘甲状腺原氨酸、甲状腺素进行评估(每组n = 5),对血浆中的血尿素氮(BUN)、肌酐进行评估(每组n = 5)。每组获取肾脏匀浆,分析肾脏超氧化物歧化酶(SOD)、还原型谷胱甘肽(GSH)和脂质过氧化(MDA)。每组还使用苏木精和伊红染色以及过碘酸希夫染色评估肾脏组织学。

结果

与其他组相比,未治疗的糖尿病组体重、血糖、胰岛素、肾脏MDA升高。与其他组相比,未治疗的糖尿病组促甲状腺激素、三碘甲状腺原氨酸、肾脏超氧化物歧化酶和谷胱甘肽水平降低(P < 0.05)。未治疗的糖尿病组肾脏组织学显示肾小球硬化、系膜细胞融合以及肾小管腔塌陷或管腔内有嗜酸性肾管型。这些病变在其他实验组中部分得到逆转。

结论

本研究表明实验性2型糖尿病可能存在甲状腺和肾脏损害。口服镁治疗可能会使甲状腺功能部分恢复,这可能会阻碍肾功能障碍的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87c8/6513790/9a3e9d3bc201/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验